Lundbeck A. S. H serves as Executive at ALDER BIOPHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Lundbeck A. S. H has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 16, 2020 involved exercising options for 79,229 shares valued at $0.
Lundbeck A. S. H currently holds 522,499 shares of ALDER BIOPHARMACEUTICALS INC (ALDR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lundbeck A. S. H has been a net neutral trader of ALDR stock. They have purchased $0 and sold $0 worth of shares.
Lundbeck A. S. H's most recent insider trade was on Mar 16, 2020, when they sold 79,229 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |